Xu et al., 2019 - Google Patents
Systematic optimization and evaluation of sample pretreatment methods for LC-MS-based metabolomics analysis of adherent mammalian cancer cellsXu et al., 2019
- Document ID
- 9408231144930417171
- Author
- Xu X
- Zang Q
- Zhang R
- Liu J
- He J
- Zhang R
- Abliz Z
- Publication year
- Publication venue
- Analytical Methods
External Links
Snippet
Cell metabolomics is a valuable tool in oncology. To obtain a valid description of the intracellular metabolome, sample pretreatment is critical to the metabolomics workflow, as this step might influence the reliability of research outcomes. Here we report a systematic …
- 238000002705 metabolomic 0 title abstract description 34
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ma et al. | Advances in mass spectrometry imaging for spatial cancer metabolomics | |
Danzi et al. | To metabolomics and beyond: a technological portfolio to investigate cancer metabolism | |
Patti et al. | Metabolomics: the apogee of the omics trilogy | |
Ser et al. | Extraction parameters for metabolomics from cultured cells | |
Kohler et al. | Analytical pitfalls and challenges in clinical metabolomics | |
Liu et al. | Single cell metabolomics using mass spectrometry: Techniques and data analysis | |
Vuckovic | Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry | |
Zhang et al. | Modern analytical techniques in metabolomics analysis | |
Chen et al. | Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation | |
Watrous et al. | The evolving field of imaging mass spectrometry and its impact on future biological research | |
Ting et al. | Normalization and statistical analysis of quantitative proteomics data generated by metabolic labeling | |
Schripsema | Application of NMR in plant metabolomics: techniques, problems and prospects | |
Stopka et al. | Ambient metabolic profiling and imaging of biological samples with ultrahigh molecular resolution using laser ablation electrospray ionization 21 Tesla FTICR mass spectrometry | |
Soste et al. | A sentinel protein assay for simultaneously quantifying cellular processes | |
Maniscalco et al. | Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases | |
US6258605B1 (en) | Clinical method for the genetic screening of newborns using tandem mass spectrometry | |
CN104297355A (en) | Simulative-target metabonomics analytic method based on combination of liquid chromatography and mass spectrum | |
Wang et al. | MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery | |
CN103592389A (en) | LC/MS (liquid chromatography-mass spectrometer) metabonomics analysis method based on serum of GDM (gestational diabetes mellitus) patient | |
WO2020199866A1 (en) | Biometabolomics data processing and analysis methods and apparatuses, and application thereof | |
Zhou et al. | Systematic evaluation of serum and plasma collection on the endogenous metabolome | |
Chekmeneva et al. | Ultra-Performance liquid chromatography–high-resolution mass spectrometry and direct infusion–high-resolution mass spectrometry for combined exploratory and targeted metabolic profiling of human urine | |
Xu et al. | Systematic optimization and evaluation of sample pretreatment methods for LC-MS-based metabolomics analysis of adherent mammalian cancer cells | |
Jiang et al. | Direct identification of forensic body fluids by MALDI-MS | |
Thompson et al. | An enhanced isotopic fine structure method for exact mass analysis in discovery metabolomics: FIA-CASI-FTMS |